J. A. Ellis, E. Vroom, and F. Muntoni, ENMC International Workshop: newborn screening for Duchenne muscular dystrophy, Neuromuscul Disord, vol.23, pp.682-691, 2012.

E. P. Hoffman, R. H. Brown, and L. M. Kunkel, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, vol.51, pp.919-947, 1987.

D. J. Birnkrant, K. Bushby, C. M. Bann, S. D. Apkon, A. Blackwell et al., Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management, Lancet Neurol, vol.17, pp.251-67, 2018.

E. Ciafaloni, D. J. Fox, S. Pandya, C. P. Westfield, S. Puzhankara et al., Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), J Pediatr, vol.155, pp.380-385, 2009.

A. D'amico, M. Catteruccia, G. Baranello, L. Politano, A. Govoni et al., Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: critical issues and areas for improvements, Neuromuscul Disord, vol.27, pp.447-51, 2017.

J. Vry, K. Gramsch, S. Rodger, R. Thompson, B. F. Steffensen et al., European cross-sectional survey of current care practices for Duchenne muscular dystrophy reveals regional and age-dependent differences, J Neuromuscul Dis, vol.3, pp.517-544, 2016.

L. Bello, L. P. Morgenroth, H. Gordish-dressman, E. P. Hoffman, C. M. Mcdonald et al., DMD genotypes and loss of ambulation in the CINRG Duchenne natural history study, Neurology, vol.87, pp.401-410, 2016.

H. J. Van-ruiten, V. Straub, K. Bushby, and M. Guglieri, Improving recognition of Duchenne muscular dystrophy: a retrospective case note review, Arch Dis Child, vol.99, pp.1074-1081, 2014.

D. E. Crisp, F. A. Ziter, and P. F. Bray, Diagnostic delay in Duchenne's muscular dystrophy, JAMA, vol.247, pp.478-80, 1982.

M. A. Firth, Diagnosis of Duchenne muscular dystrophy: experiences of parents of sufferers, Br Med J (Clin Res Ed), vol.286, pp.700-701, 1983.

A. Aartsma-rus, I. B. Ginjaar, and K. Bushby, The importance of genetic diagnosis for Duchenne muscular dystrophy, J Med Genet, vol.53, pp.145-51, 2016.

S. Abbs, S. Tuffery-giraud, E. Bakker, A. Ferlini, T. Sejersen et al., Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies, Neuromuscul Disord, vol.20, pp.422-429, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02446658

R. M. Rosenfeld, L. C. Nnacheta, and M. D. Corrigan, Clinical consensus statement development manual, Otolaryngol Head Neck Surg, vol.153, pp.1-14, 2015.

G. H. Guyatt, D. J. Cook, D. L. Sackett, M. Eckman, and S. Pauker, Grades of recommendation for antithrombotic agents, Chest, vol.114, pp.441-444, 1998.

G. H. Guyatt, A. D. Oxman, R. Kunz, Y. Falck-ytter, G. E. Vist et al., GRADE: going from evidence to recommendations, BMJ, vol.336, pp.1049-51, 2008.

G. H. Guyatt, A. D. Oxman, G. E. Vist, R. Kunz, Y. Falck-ytter et al., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, vol.336, pp.924-930, 2008.

G. H. Guyatt, A. D. Oxman, G. E. Vist, R. Kunz, Y. Falck-ytter et al., GRADE: what is "quality of evidence" and why is it important to clinicians?, BMJ, vol.336, pp.995-1003, 2008.

K. Bushby, R. Finkel, D. J. Birnkrant, L. E. Case, P. R. Clemens et al., Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management, Lancet Neurol, vol.9, pp.77-93, 2010.

S. H. Wong, B. J. Mcclaren, A. D. Archibald, A. Weeks, T. Langmaid et al., A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy, Eur J Hum Genet, vol.23, pp.1294-300, 2015.

S. J. Na, W. J. Kim, S. M. Kim, K. O. Lee, B. Yoon et al., Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy, J Clin Neurosci, vol.20, pp.1099-105, 2013.

S. Dey, A. K. Senapati, A. Pandit, A. Biswas, D. S. Guin et al., Genetic and clinical profile of patients of Duchenne muscular dystrophy: experience from a tertiary care center in Eastern India, Indian Pediatr, vol.52, pp.481-485, 2015.

C. Holtzer, F. J. Meaney, J. Andrews, E. Ciafaloni, D. J. Fox et al., Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy, Genet Med, vol.13, pp.942-949, 2011.

F. Magri, A. Govoni, D. Angelo, M. G. , D. Bo et al., Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up, J Neurol, vol.258, pp.1610-1633, 2011.

V. Ricotti, W. P. Mandy, M. Scoto, M. Pane, N. Deconinck et al., Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev Med Child Neurol, vol.58, pp.77-84, 2016.

E. Sarrazin, V. Der-hagen, M. Schara, U. , V. Au et al., Growth and psychomotor development of patients with Duchenne muscular dystrophy, Eur J Paediatr Neurol, vol.18, pp.38-44, 2014.

P. Colombo, M. Nobile, A. Tesei, F. Civati, S. Gandossini et al., Assessing mental health in boys with Duchenne muscular dystrophy: emotional, behavioural and neurodevelopmental profile in an Italian clinical sample, Eur J Paediatr Neurol, vol.21, pp.639-686, 2017.

R. Latimer, N. Street, K. C. Conway, K. James, C. Cunniff et al., Secondary conditions among males with Duchenne or Becker muscular dystrophy, J Child Neurol, vol.32, pp.663-70, 2017.

K. T. Mirski and T. O. Crawford, Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosis, J Pediatr, vol.165, pp.1008-1018, 2014.

W. M. Snow, J. E. Anderson, and L. S. Jakobson, Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review, Neurosci Biobehav Rev, vol.37, pp.743-52, 2013.

S. Vicari, G. Piccini, E. Mercuri, R. Battini, D. Chieffo et al., Implicit learning deficit in children with Duchenne muscular dystrophy: evidence for a cerebellar cognitive impairment?, PLoS ONE, vol.13, p.191164, 2018.

A. Araujo, A. Carvalho, E. Cavalcanti, J. Saute, E. Carvalho et al., Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives, Arq Neuropsiquiatr, vol.75, pp.104-117, 2017.

B. P. Hughes, Serum enzyme changes in muscle disease and their relation to tissue change, Proc R Soc Med, vol.56, pp.179-82, 1963.

E. M. Strehle and V. Straub, Recent advances in the management of Duchenne muscular dystrophy, Arch Dis Child, vol.100, pp.1173-1180, 2015.

M. R. Hegde, E. L. Chin, J. G. Mulle, D. T. Okou, S. T. Warren et al., Microarray-based mutation detection in the dystrophin gene, Hum Mutat, vol.29, pp.1091-1100, 2008.

C. L. Bladen, D. Salgado, S. Monges, M. E. Foncuberta, K. Kekou et al., The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations, Hum Mutat, vol.36, pp.395-402, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01681769

J. Juan-mateu, L. Gonzalez-quereda, M. J. Rodriguez, M. Baena, E. Verdura et al., DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations, PLoS ONE, vol.10, p.135189, 2015.

J. Zhong, T. Xu, G. Chen, H. Liao, J. Zhang et al., Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophies, Muscle Nerve, vol.56, pp.117-138, 2017.

T. Lalic, R. H. Vossen, J. Coffa, J. P. Schouten, M. Guc-scekic et al., Deletion and duplication screening in the DMD gene using MLPA, Eur J Hum Genet, vol.13, pp.1231-1235, 2005.

M. Manjunath, P. Kiran, V. Preethish-kumar, A. Nalini, R. J. Singh et al., A comparative study of mPCR, MLPA, and muscle biopsy results in a cohort of children with Duchenne muscular dystrophy: a first study, Neurol India, vol.63, pp.58-62, 2015.

F. Khordadpoor-deilamani, M. T. Akbari, S. Nafissi, and G. Zamani, Dystrophin gene mutation analysis in Iranian males and females using multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification methods, Genet Test Mol Biomarkers, vol.15, p.893, 2011.

R. S. Dastur, M. Y. Kachwala, S. V. Khadilkar, M. R. Hegde, and P. S. Gaitonde, Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification, Neurol India, vol.59, pp.803-812, 2011.

M. Bovolenta, M. Neri, S. Fini, M. Fabris, C. Trabanelli et al., A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies, BMC Genomics, vol.9, p.572, 2008.

B. Baskin, W. T. Gibson, and P. N. Ray, Duchenne muscular dystrophy caused by a complex rearrangement between intron 43 of the DMD gene and chromosome 4, Neuromuscul Disord, vol.21, pp.178-82, 2011.

A. Ishmukhametova, K. Van-kien, P. Mechin, D. Thorel, D. Vincent et al., Comprehensive oligonucleotide array-comparative genomic hybridization analysis: new insights into the molecular pathology of the DMD gene, Eur J Hum Genet, vol.20, pp.1096-100, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02444080

R. Santos, A. Goncalves, J. Oliveira, E. Vieira, J. P. Vieira et al., New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy, J Hum Genet, vol.59, pp.454-64, 2014.

S. Tuffery-giraud, J. Miro, M. Koenig, and M. Claustres, Normal and altered pre-mRNA processing in the DMD gene, Hum Genet, vol.136, pp.1155-72, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01760830

R. Boulez, F. Menassa, R. Streichenberger, N. Manel, V. Mallet-motak et al., A splicing mutation in the DMD gene detected by next-generation sequencing and confirmed by mRNA and protein analysis, Clin Chim Acta, vol.448, pp.146-155, 2015.

F. Magri, D. Bo, R. , D. Angelo, M. G. Govoni et al., Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the dystrophin gene detected by direct sequencing, BMC Med Genet, vol.12, p.37, 2011.

E. Niba, A. Nishida, V. K. Tran, D. C. Vu, M. Matsumoto et al., Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361 + 1G>A mutation identified by NGS, J Hum Genet, vol.62, pp.531-538, 2017.

Z. Wang, Y. Lin, L. Qiu, D. Zheng, A. Yan et al., Hybrid minigene splicing assay verified the pathogenicity of a novel splice site variant in the dystrophin gene of a Chinese patient with typical Duchenne muscular dystrophy phenotype, Clin Chem Lab Med, vol.54, pp.1435-1475, 2016.

B. Baskin, D. J. Stavropoulos, P. A. Rebeiro, J. Orr, M. Li et al., Complex genomic rearrangements in the dystrophin gene due to replication-based mechanisms, Mol Genet Genomic Med, vol.2, pp.539-586, 2014.

M. M. Khelifi, A. Ishmukhametova, K. Van-kien, P. Thorel, D. Mechin et al., Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations?, Hum Mutat, vol.32, pp.467-75, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00621292

K. Greer, K. Mizzi, E. Rice, L. Kuster, R. A. Barrero et al., Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient, Mol Genet Genomic Med, vol.3, pp.320-326, 2015.

A. K. Zaum, B. Stuve, A. Gehrig, H. Kolbel, U. Schara et al., Deep intronic variants introduce DMD pseudoexon in patient with muscular dystrophy, Neuromuscul Disord, vol.27, pp.631-635, 2017.

M. S. Williams, Genetics and managed care: policy statement of the American College of Medical Genetics, Genet Med, vol.3, pp.430-435, 2001.

M. J. Baars, L. Henneman, T. Kate, and L. P. , Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem, Genet Med, vol.7, pp.605-615, 2005.

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-429, 2015.

V. C. Thurston, P. S. Wales, M. A. Bell, L. Torbeck, and J. J. Brokaw, The current status of medical genetics instruction in US and Canadian medical schools, Acad Med, vol.82, pp.441-446, 2007.

A. E. Greb, S. Brennan, L. Mcparlane, R. Page, and P. D. Bridge, Retention of medical genetics knowledge and skills by medical students, Genet Med, vol.11, pp.365-70, 2009.

R. Klitzman, W. Chung, K. Marder, A. Shanmugham, L. J. Chin et al., Attitudes and practices among internists concerning genetic testing, J Genet Couns, vol.22, pp.90-100, 2013.

S. Burke, A. Stone, J. Bedward, H. Thomas, and P. Farndon, A "neglected part of the curriculum" or "of limited use"? Views on genetics training by nongenetics medical trainees and implications for delivery, Genet Med, vol.8, pp.109-124, 2006.

A. E. Shields, W. Burke, and D. E. Levy, Differential use of available genetic tests among primary care physicians in the United States: results of a national survey, Genet Med, vol.10, pp.404-418, 2008.

T. Lee, Y. Takeshima, N. Kusunoki, H. Awano, M. Yagi et al., Differences in carrier frequency between mothers of Duchenne and Becker muscular dystrophy patients, J Hum Genet, vol.59, pp.46-50, 2014.

A. Helderman-van-den-enden, J. C. Van-den-bergen, M. H. Breuning, J. Verschuuren, A. Tibben et al., Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?, Clin Genet, vol.79, pp.236-278, 2011.

J. Juan-mateu, M. J. Rodriguez, A. Nascimento, C. Jimenez-mallebrera, L. Gonzalez-quereda et al., Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy, Orphanet J Rare Dis, vol.7, p.82, 2012.

R. Papa, F. Madia, D. Bartolomeo, F. Trucco, M. Pedemonte et al., Genetic and early clinical manifestations of females heterozygous for Duchenne/Becker muscular dystrophy, Pediatr Neurol, vol.55, pp.58-63, 2016.

T. Mccaffrey, M. Guglieri, A. P. Murphy, K. Bushby, A. Johnson et al., Cardiac involvement in female carriers of Duchenne or Becker muscular dystrophy, Muscle Nerve, vol.55, pp.810-818, 2017.

J. Schelhorn, A. Schoenecker, U. Neudorf, H. Schemuth, F. Nensa et al., Cardiac pathologies in female carriers of Duchenne muscular dystrophy assessed by cardiovascular magnetic resonance imaging, Eur Radiol, vol.25, pp.3066-72, 2015.

A. Florian, S. Rosch, M. Bietenbeck, M. Engelen, J. Stypmann et al., Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study, Eur Heart J Cardiovasc Imaging, vol.17, pp.326-359, 2016.

L. Bogue, H. Peay, A. Martin, A. Lucas, and S. Ramchandren, Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy, Neuromuscul Disord, vol.26, pp.860-864, 2016.

G. Plumridge, A. Metcalfe, J. Coad, and P. Gill, Parents' communication with siblings of children affected by an inherited genetic condition, J Genet Couns, vol.20, pp.374-83, 2011.

E. P. Hoffman, K. Arahata, C. Minetti, E. Bonilla, and L. P. Rowland, Dystrophinopathy in isolated cases of myopathy in females, Neurology, vol.42, pp.967-75, 1992.

L. Bogue and S. Ramchandren, Outdated risk assessment in a family with Duchenne dystrophy: implications for duty to reassess, Neurol Genet, vol.2, p.103, 2016.

A. Lehmann, B. S. Speight, and L. Kerzin-storrar, Extended family impact of genetic testing: the experiences of X-linked carrier grandmothers, J Genet Couns, vol.20, pp.365-73, 2011.

R. M. Hightower and M. S. Alexander, Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies, Muscle Nerve, vol.57, pp.6-15, 2018.

R. Pons, K. Kekou, A. Gkika, G. Papadimas, N. Vogiatzakis et al., Single amino acid loss in the dystrophin protein associated with a mild clinical phenotype, Muscle Nerve, vol.55, pp.46-50, 2017.

P. J. Taylor, G. A. Betts, S. Maroulis, C. Gilissen, R. L. Pedersen et al., Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS ONE, vol.5, p.8803, 2010.

V. Ricotti, H. Jagle, M. Theodorou, A. T. Moore, F. Muntoni et al., Ocular and neurodevelopmental features of Duchenne muscular THE JOURNAL OF PEDIATRICS ? www, vol.204

, dystrophy: a signature of dystrophin function in the central nervous system, Eur J Hum Genet, vol.24, pp.562-570, 2016.

J. C. Van-den-bergen, H. B. Ginjaar, E. H. Niks, A. Aartsma-rus, and J. J. Verschuuren, Prolonged ambulation in Duchenne patients with a mutation amenable to exon 44 skipping, J Neuromuscul Dis, vol.1, pp.91-95, 2014.

A. Barp, L. Bello, L. Politano, P. Melacini, C. Calore et al., Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy, PLoS ONE, vol.10, p.141240, 2015.

L. Imbornoni, E. T. Price, J. Andrews, F. J. Meaney, E. Ciafaloni et al., Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy, Am J Med Genet A, vol.164, pp.2769-74, 2014.

S. Mercier, A. Toutain, A. Toussaint, M. Raynaud, C. De-barace et al., Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age, Eur J Hum Genet, vol.21, pp.855-63, 2013.

S. M. Lang, S. Shugh, W. Mazur, J. J. Sticka, M. S. Rattan et al., Myocardial fibrosis and left ventricular dysfunction in Duchenne muscular dystrophy carriers using cardiac magnetic resonance imaging, Pediatr Cardiol, vol.36, pp.1495-501, 2015.

K. T. Nozoe, R. T. Akamine, D. R. Mazzotti, D. N. Polesel, L. F. Grossklauss et al., Phenotypic contrasts of Duchenne muscular dystrophy in women: two case reports, Sleep Sci, vol.9, pp.129-162, 2016.

J. J. Parent, R. A. Moore, M. D. Taylor, J. A. Towbin, and J. L. Jefferies, Left ventricular noncompaction cardiomyopathy in Duchenne muscular dystrophy carriers, J Cardiol Cases, vol.11, pp.7-9, 2015.

V. E. Cheng and D. L. Prior, Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy, Heart Lung Circ, vol.22, pp.677-81, 2013.

H. R. Martinez, R. Pignatelli, J. W. Belmont, W. J. Craigen, and J. L. Jefferies, Childhood onset of left ventricular dysfunction in a female manifesting carrier of muscular dystrophy, Am J Med Genet A, vol.155, pp.3025-3034, 2011.

A. Yilmaz, H. J. Gdynia, A. C. Ludolph, K. Klingel, R. Kandolf et al., Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI, Circulation, vol.121, pp.237-246, 2010.

T. Walcher, M. Kunze, P. Steinbach, A. D. Sperfeld, C. Burgstahler et al., Cardiac involvement in a female carrier of Duchenne muscular dystrophy, Int J Cardiol, vol.138, pp.302-307, 2010.

R. Mcgowan, B. R. Challoner, S. Ross, S. Holloway, S. Joss et al., Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades?, Clin Genet, vol.83, pp.187-90, 2013.

C. Bermudez-lopez, B. Garcia-de-teresa, G. Angel, A. , and A. Ma, Germinal mosaicism in a sample of families with Duchenne/Becker muscular dystrophy with partial deletions in the DMD gene, Genet Test Mol Biomarkers, vol.18, pp.93-100, 2014.

S. Garcia, T. De-haro, M. Zafra-ceres, A. Poyatos, J. A. Gomez-capilla et al., Identification of de novo mutations of Duchenne/Becker muscular dystrophies in southern Spain, Int J Med Sci, vol.11, pp.988-93, 2014.

L. Strmecki, P. Hudler, M. Benedik-dolnicar, and R. Komel, De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy, Int J Hematol, vol.99, pp.184-191, 2014.

A. B. Luna-angulo, B. Gomez-diaz, R. E. Escobar-cedillo, M. A. Anaya-segura, F. J. Estrada-mena et al., A new de novo mutation in a non-hot spot region at the DMD gene in a Mexican family, Genet Couns, vol.25, pp.429-461, 2014.

T. Li, Z. J. Zhang, X. Ma, X. Lv, H. Xiao et al., Prenatal diagnosis for a Chinese family with a de novo DMD gene mutation: a case report, Medicine (Baltimore), vol.96, p.8814, 2017.

J. R. Mendell, C. Shilling, N. D. Leslie, K. M. Flanigan, R. Dahhak et al., Evidence-based path to newborn screening for Duchenne muscular dystrophy, Ann Neurol, vol.71, pp.304-317, 2012.

S. J. Moat, D. M. Bradley, R. Salmon, A. Clarke, and L. Hartley, Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK), Eur J Hum Genet, vol.21, pp.1049-53, 2013.

Q. Ke, Z. Y. Zhao, R. Griggs, V. Wiley, A. Connolly et al., Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment, World J Pediatr, vol.13, pp.197-201, 2017.

M. F. Wood, S. C. Hughes, L. P. Hache, E. W. Naylor, A. Hz et al., Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy, Muscle Nerve, vol.49, pp.822-830, 2014.

S. E. Lillie, B. A. Tarini, N. K. Janz, and B. J. Zikmund-fisher, Framing optional genetic testing in the context of mandatory newborn screening tests, BMC Med Inform Decis Mak, vol.15, p.50, 2015.

A. T. Helderman-van-den-enden, K. Madan, M. H. Breuning, A. H. Van-der-hout, E. Bakker et al., An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy, Eur J Hum Genet, vol.21, pp.21-27, 2013.

H. Wang, Y. Xu, X. Liu, L. Wang, W. Jiang et al., Prenatal diagnosis of Duchenne muscular dystrophy in 131 Chinese families with dystrophinopathy, Prenat Diagn, vol.37, pp.356-64, 2017.

S. Moghadam-kia, C. V. Oddis, and R. Aggarwal, Approach to asymptomatic creatine kinase elevation, Cleve Clin J Med, vol.83, pp.37-42, 2016.

, EBI Search: gene & protein summary for dystrophin, 2018.

T. Grimm, W. Kress, G. Meng, and C. R. Muller, Risk assessment and genetic counseling in families with Duchenne muscular dystrophy, Acta Myol, vol.31, pp.179-83, 2012.

Y. Takeshima, M. Yagi, Y. Okizuka, H. Awano, Z. Zhang et al., Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center, J Hum Genet, vol.55, pp.379-88, 2010.

A. Q. Rani, T. H. Sasongko, S. Sulong, D. Bunyan, A. R. Salmi et al., Mutation spectrum of dystrophin gene in Malaysian patients with Duchenne/Becker muscular dystrophy, J Neurogenet, vol.27, pp.11-16, 2013.

J. G. Zimowski, D. Massalska, M. Holding, S. Jadczak, E. Fidzianska et al., MLPA based detection of mutations in the dystrophin gene of 180 Polish families with Duchenne/Becker muscular dystrophy, Neurol Neurochir Pol, vol.48, pp.416-438, 2014.

P. A. De-almeida, M. C. Machado-costa, G. N. Manzoli, L. S. Ferreira, M. C. Rodrigues et al., Genetic profile of Brazilian patients with dystrophinopathies, Clin Genet, vol.92, pp.199-203, 2017.

E. Ramos, J. G. Conde, R. A. Berrios, S. Pardo, O. Gomez et al., Prevalence and genetic profile of Duchene and Becker muscular dystrophy in Puerto Rico, J Neuromuscul Dis, vol.3, pp.261-267, 2016.

A. Griffiths, W. M. Gelbart, J. H. Miller, and R. C. Lewontin, Chromosomal rearrangements. In: Modern genetic analysis, 1999.

Y. Wang, Y. Yang, J. Liu, X. C. Chen, X. Liu et al., Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy, Mol Genet Genomics, vol.289, pp.1013-1034, 2014.

B. B. Cummings, J. L. Marshall, T. Tukiainen, M. Lek, S. Donkervoort et al., Improving genetic diagnosis in Mendelian disease with transcriptome sequencing, Sci Transl Med, vol.9, p.5209, 2017.

L. Bello, A. Kesari, H. Gordish-dressman, A. Cnaan, L. P. Morgenroth et al., Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne natural history study, Ann Neurol, vol.77, pp.684-96, 2015.

G. H. Guyatt, D. J. Cook, D. L. Sackett, M. Eckman, and S. Pauker, Grades of recommendation for antithrombotic agents, Chest, vol.114, pp.441-444, 1998.

G. H. Guyatt, A. D. Oxman, R. Kunz, Y. Falck-ytter, G. E. Vist et al., GRADE: going from evidence to recommendations, BMJ, vol.336, pp.1049-51, 2008.

G. H. Guyatt, A. D. Oxman, G. E. Vist, R. Kunz, Y. Falck-ytter et al., GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, vol.336, pp.924-930, 2008.

G. H. Guyatt, A. D. Oxman, G. E. Vist, R. Kunz, Y. Falck-ytter et al., GRADE: what is "quality of evidence" and why is it important to clinicians?, BMJ, vol.336, pp.995-1003, 2008.

E. Ciafaloni, D. J. Fox, S. Pandya, C. P. Westfield, S. Puzhankara et al., Delayed diagnosis in Duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet), J Pediatr, vol.155, pp.380-385, 2009.

S. H. Wong, B. J. Mcclaren, A. D. Archibald, A. Weeks, T. Langmaid et al., A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy, Eur J Hum Genet, vol.23, pp.1294-300, 2015.

H. J. Van-ruiten, V. Straub, K. Bushby, and M. Guglieri, Improving recognition of Duchenne muscular dystrophy: a retrospective case note review, Arch Dis Child, vol.99, pp.1074-1081, 2014.

S. J. Na, W. J. Kim, S. M. Kim, K. O. Lee, B. Yoon et al., Clinical, immunohistochemical, Western blot, and genetic analysis in dystrophinopathy, J Clin Neurosci, vol.20, pp.1099-105, 2013.

S. Dey, A. K. Senapati, A. Pandit, A. Biswas, D. S. Guin et al., Genetic and clinical profile of patients of Duchenne muscular dystrophy: experience from a tertiary care center in Eastern India, Indian Pediatr, vol.52, pp.481-485, 2015.

C. Holtzer, F. J. Meaney, J. Andrews, E. Ciafaloni, D. J. Fox et al., Disparities in the diagnostic process of Duchenne and Becker muscular dystrophy, Genet Med, vol.13, pp.942-949, 2011.

V. Ricotti, W. P. Mandy, M. Scoto, M. Pane, N. Deconinck et al., Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev Med Child Neurol, vol.58, pp.77-84, 2016.

E. Sarrazin, V. Der-hagen, M. Schara, U. , V. Au et al., Growth and psychomotor development of patients with Duchenne muscular dystrophy, Eur J Paediatr Neurol, vol.18, pp.38-44, 2014.

R. Latimer, N. Street, K. C. Conway, K. James, C. Cunniff et al., Secondary conditions among males with Duchenne or Becker muscular dystrophy, J Child Neurol, vol.32, pp.663-70, 2017.

K. T. Mirski and T. O. Crawford, Motor and cognitive delay in Duchenne muscular dystrophy: implication for early diagnosis, J Pediatr, vol.165, pp.1008-1018, 2014.

S. Vicari, G. Piccini, E. Mercuri, R. Battini, D. Chieffo et al., Implicit learning deficit in children with Duchenne muscular dystrophy: evidence for a cerebellar cognitive impairment?, PLoS ONE, vol.13, p.191164, 2018.

P. Colombo, M. Nobile, A. Tesei, F. Civati, S. Gandossini et al., Assessing mental health in boys with Duchenne muscular dystrophy: emotional, behavioural and neurodevelopmental profile in an Italian clinical sample, Eur J Paediatr Neurol, vol.21, pp.639-686, 2017.

F. Magri, A. Govoni, D. Angelo, M. G. , D. Bo et al., Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up, J Neurol, vol.258, pp.1610-1633, 2011.

W. M. Snow, J. E. Anderson, and L. S. Jakobson, Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review, Neurosci Biobehav Rev, vol.37, pp.743-52, 2013.

B. P. Hughes, Serum enzyme changes in muscle disease and their relation to tissue change, Proc R Soc Med, vol.56, pp.179-82, 1963.

E. M. Strehle and V. Straub, Recent advances in the management of Duchenne muscular dystrophy, Arch Dis Child, vol.100, pp.1173-1180, 2015.

J. Vry, K. Gramsch, S. Rodger, R. Thompson, B. F. Steffensen et al., European cross-sectional survey of current care practices for Duchenne muscular dystrophy reveals regional and age-dependent differences, J Neuromuscul Dis, vol.3, pp.517-544, 2016.

A. Aartsma-rus, I. B. Ginjaar, and K. Bushby, The importance of genetic diagnosis for Duchenne muscular dystrophy, J Med Genet, vol.53, pp.145-51, 2016.

A. European-medicines, Translarna? summary of product characteristics, 2018.

, EXONDYS 51? (eteplirsen) injection label. Highlights of prescribing information, 2018.

, FDA News Release: FDA grants accelerated approval to first drug for Duchenne muscular dystrophy, 2018.

, Leiden Open Variation Database (LOVD). www.dmd.nl, 2018.

. Umd-dmd and . Treat-nmd, The UMD TREAT-NMD DMD mutations database, 2018.

, Institute of Medical Genetics in Cardiff. The Human Gene Mutation Database, 2018.

S. Abbs, S. Tuffery-giraud, E. Bakker, A. Ferlini, T. Sejersen et al., Best practice guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies, Neuromuscul Disord, vol.20, pp.422-429, 2010.
URL : https://hal.archives-ouvertes.fr/hal-02446658

T. Lalic, R. H. Vossen, J. Coffa, J. P. Schouten, M. Guc-scekic et al., Deletion and duplication screening in the DMD gene using MLPA, Eur J Hum Genet, vol.13, pp.1231-1235, 2005.

M. Manjunath, P. Kiran, V. Preethish-kumar, A. Nalini, R. J. Singh et al., A comparative study of mPCR, MLPA, and muscle biopsy results in a cohort of children with Duchenne muscular dystrophy: a first study, Neurol India, vol.63, pp.58-62, 2015.

F. Khordadpoor-deilamani, M. T. Akbari, S. Nafissi, and G. Zamani, Dystrophin gene mutation analysis in Iranian males and females using multiplex polymerase chain reaction and multiplex ligation-dependent probe amplification methods, Genet Test Mol Biomarkers, vol.15, pp.893-902, 2011.

R. S. Dastur, M. Y. Kachwala, S. V. Khadilkar, M. R. Hegde, and P. S. Gaitonde, Identification of deletions and duplications in the Duchenne muscular dystrophy gene and female carrier status in western India using combined methods of multiplex polymerase chain reaction and multiplex ligationdependent probe amplification, Neurol India, vol.59, pp.803-812, 2011.

Y. Xu, H. Wang, X. B. Wei, W. Liu, Y. Ye et al., Novel noncontiguous duplications identified with a comprehensive mutation analysis in the DMD gene by DMD gene-targeted sequencing, Gene, vol.645, pp.113-121, 2018.

M. J. Kim, S. I. Cho, J. H. Chae, B. C. Lim, J. S. Lee et al., Pitfalls of multiple ligation-dependent probe amplifications in detecting DMD exon deletions or duplications, J Mol Diagn, vol.18, pp.253-262, 2016.

R. Santos, A. Goncalves, J. Oliveira, E. Vieira, J. P. Vieira et al., New variants, challenges and pitfalls in DMD genotyping: implications in diagnosis, prognosis and therapy, J Hum Genet, vol.59, pp.454-64, 2014.

A. Araujo, A. Carvalho, E. Cavalcanti, J. Saute, E. Carvalho et al., Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives, Arq Neuropsiquiatr, vol.75, pp.104-117, 2017.

M. Bovolenta, M. Neri, S. Fini, M. Fabris, C. Trabanelli et al., A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies, BMC Genomics, vol.9, p.572, 2008.

B. Baskin, W. T. Gibson, and P. N. Ray, Duchenne muscular dystrophy caused by a complex rearrangement between intron 43 of the DMD gene and chromosome 4, Neuromuscul Disord, vol.21, pp.178-82, 2011.

A. Ishmukhametova, K. Van-kien, P. Mechin, D. Thorel, D. Vincent et al., Comprehensive oligonucleotide array-comparative genomic hybridization analysis: new insights into the molecular pathology of the DMD gene, Eur J Hum Genet, vol.20, pp.1096-100, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02444080

M. R. Hegde, E. L. Chin, J. G. Mulle, D. T. Okou, S. T. Warren et al., Microarray-based mutation detection in the dystrophin gene, Hum Mutat, vol.29, pp.1091-1100, 2008.

K. Bushby, R. Finkel, D. J. Birnkrant, L. E. Case, P. R. Clemens et al., Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management, Lancet Neurol, vol.9, pp.77-93, 2010.

D. J. Birnkrant, K. Bushby, C. M. Bann, S. D. Apkon, A. Blackwell et al., Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management, Lancet Neurol, vol.17, pp.251-67, 2018.

Y. Wang, Y. Yang, J. Liu, X. C. Chen, X. Liu et al., Whole dystrophin gene analysis by next-generation sequencing: a comprehensive genetic diagnosis of Duchenne and Becker muscular dystrophy, Mol Genet Genomics, vol.289, pp.1013-1034, 2014.

M. Alame, D. Lacourt, R. Zenagui, D. Mechin, F. Danton et al., Implementation of a reliable next-generation sequencing strategy for molecular diagnosis of dystrophinopathies, J Mol Diagn, vol.18, pp.731-771, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01844590

C. L. Bladen, D. Salgado, S. Monges, M. E. Foncuberta, K. Kekou et al., The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations, Hum Mutat, vol.36, pp.395-402, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01681769

N. Vasli, J. Bohm, L. Gras, S. Muller, J. Pizot et al., Next generation sequencing for molecular diagnosis of neuromuscular diseases, Acta Neuropathol, vol.124, pp.273-83, 2012.

B. C. Lim, S. Lee, J. Y. Shin, J. I. Kim, H. Hwang et al., Genetic diagnosis of Duchenne and Becker muscular dystrophy using next-generation sequencing technology: comprehensive mutational search in a single platform, J Med Genet, vol.48, pp.731-737, 2011.

K. M. Flanigan, A. Von-niederhausern, D. M. Dunn, J. Alder, J. R. Mendell et al., Rapid direct sequence analysis of the dystrophin gene, Am J Hum Genet, vol.72, pp.931-940, 2003.

X. Wei, Y. Dai, P. Yu, N. Qu, Z. Lan et al., Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: a multi-population diagnostic study, Eur J Hum Genet, vol.22, pp.110-118, 2014.

R. Boulez, F. Menassa, R. Streichenberger, N. Manel, V. Mallet-motak et al., A splicing mutation in the DMD gene detected by next-generation sequencing and confirmed by mRNA and protein analysis, Clin Chim Acta, vol.448, pp.146-155, 2015.

F. Magri, D. Bo, R. , D. Angelo, M. G. Govoni et al., Clinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the dystrophin gene detected by direct sequencing, BMC Med Genet, vol.12, p.37, 2011.

E. Niba, A. Nishida, V. K. Tran, D. C. Vu, M. Matsumoto et al., Cryptic splice activation but not exon skipping is observed in minigene assays of dystrophin c.9361 + 1G>A mutation identified by NGS, J Hum Genet, vol.62, pp.531-538, 2017.

Z. Wang, Y. Lin, L. Qiu, D. Zheng, A. Yan et al., Hybrid minigene splicing assay verified the pathogenicity of a novel splice site variant in the dystrophin gene of a Chinese patient with typical Duchenne muscular dystrophy phenotype, Clin Chem Lab Med, vol.54, pp.1435-1475, 2016.

B. Baskin, D. J. Stavropoulos, P. A. Rebeiro, J. Orr, M. Li et al., Complex genomic rearrangements in the dystrophin gene due to replication-based mechanisms, Mol Genet Genomic Med, vol.2, pp.539-586, 2014.

M. M. Khelifi, A. Ishmukhametova, K. Van-kien, P. Thorel, D. Mechin et al., Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations?, Hum Mutat, vol.32, pp.467-75, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00621292

A. K. Zaum, B. Stuve, A. Gehrig, H. Kolbel, U. Schara et al., Deep intronic variants introduce DMD pseudoexon in patient with muscular dystrophy, Neuromuscul Disord, vol.27, pp.631-635, 2017.

S. Tuffery-giraud, J. Miro, M. Koenig, and M. Claustres, Normal and altered pre-mRNA processing in the DMD gene, Hum Genet, vol.136, pp.1155-72, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01760830

K. Greer, K. Mizzi, E. Rice, L. Kuster, R. A. Barrero et al., Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient, Mol Genet Genomic Med, vol.3, pp.320-326, 2015.

, The International Laboratory Accreditation Cooperation (ILAC), 2018.

S. Richards, N. Aziz, S. Bale, D. Bick, S. Das et al., Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med, vol.17, pp.405-429, 2015.

S. Burke, A. Stone, J. Bedward, H. Thomas, and P. Farndon, A "neglected part of the curriculum" or "of limited use"? Views on genetics training by nongenetics medical trainees and implications for delivery, Genet Med, vol.8, pp.109-124, 2006.

R. Klitzman, W. Chung, K. Marder, A. Shanmugham, L. J. Chin et al., Attitudes and practices among internists concerning genetic testing, J Genet Couns, vol.22, pp.90-100, 2013.

A. Lehmann, B. S. Speight, and L. Kerzin-storrar, Extended family impact of genetic testing: the experiences of X-linked carrier grandmothers, J Genet Couns, vol.20, pp.365-73, 2011.

G. Plumridge, A. Metcalfe, J. Coad, and P. Gill, Parents' communication with siblings of children affected by an inherited genetic condition, J Genet Couns, vol.20, pp.374-83, 2011.

L. Bello, L. P. Morgenroth, H. Gordish-dressman, E. P. Hoffman, C. M. Mcdonald et al., DMD genotypes and loss of ambulation in the CINRG Duchenne natural history study, Neurology, vol.87, pp.401-410, 2016.

L. Bello, A. Kesari, H. Gordish-dressman, A. Cnaan, L. P. Morgenroth et al., Genetic modifiers of ambulation in the Cooperative International Neuromuscular Research Group Duchenne natural history study, Ann Neurol, vol.77, pp.684-96, 2015.

J. C. Van-den-bergen, H. B. Ginjaar, E. H. Niks, A. Aartsma-rus, and J. J. Verschuuren, Prolonged ambulation in Duchenne patients with a mutation amenable to exon 44 skipping, J Neuromuscul Dis, vol.1, pp.91-95, 2014.

C. Bermudez-lopez, B. Garcia-de-teresa, G. Angel, A. , and A. Ma, Germinal mosaicism in a sample of families with Duchenne/Becker muscular dystrophy with partial deletions in the DMD gene, Genet Test Mol Biomarkers, vol.18, pp.93-100, 2014.

S. Garcia, T. De-haro, M. Zafra-ceres, A. Poyatos, J. A. Gomez-capilla et al., Identification of de novo mutations of Duchenne/Becker muscular dystrophies in southern Spain, Int J Med Sci, vol.11, pp.988-93, 2014.

L. Strmecki, P. Hudler, M. Benedik-dolnicar, and R. Komel, De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy, Int J Hematol, vol.99, pp.184-191, 2014.

A. B. Luna-angulo, B. Gomez-diaz, R. E. Escobar-cedillo, M. A. Anaya-segura, F. J. Estrada-mena et al., A new de novo mutation in a non-hot spot region at the DMD gene in a Mexican family, Genet Couns, vol.25, pp.429-461, 2014.

T. Li, Z. J. Zhang, X. Ma, X. Lv, H. Xiao et al., Prenatal diagnosis for a Chinese family with a de novo DMD gene mutation: a case report, Medicine (Baltimore), vol.96, p.8814, 2017.

J. Juan-mateu, M. J. Rodriguez, A. Nascimento, C. Jimenez-mallebrera, L. Gonzalez-quereda et al., Prognostic value of X-chromosome inactivation in symptomatic female carriers of dystrophinopathy, Orphanet J Rare Dis, vol.7, p.82, 2012.

R. Papa, F. Madia, D. Bartolomeo, F. Trucco, M. Pedemonte et al., Genetic and early clinical manifestations of females heterozygous for Duchenne/Becker muscular dystrophy, Pediatr Neurol, vol.55, pp.58-63, 2016.

K. T. Nozoe, R. T. Akamine, D. R. Mazzotti, D. N. Polesel, L. F. Grossklauss et al., Phenotypic contrasts of Duchenne muscular dystrophy in women: two case reports, Sleep Sci, vol.9, pp.129-162, 2016.

E. Takeshita, N. Minami, K. Minami, M. Suzuki, T. Awashima et al., Duchenne muscular dystrophy in a female with compound heterozygous contiguous exon deletions, Neuromuscul Disord, vol.27, pp.569-73, 2017.

L. Imbornoni, E. T. Price, J. Andrews, F. J. Meaney, E. Ciafaloni et al., Diagnostic and clinical characteristics of early-manifesting females with Duchenne or Becker muscular dystrophy, Am J Med Genet A, vol.164, pp.2769-74, 2014.

S. Mercier, A. Toutain, A. Toussaint, M. Raynaud, C. De-barace et al., Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age, Eur J Hum Genet, vol.21, pp.855-63, 2013.

A. Florian, S. Rosch, M. Bietenbeck, M. Engelen, J. Stypmann et al., Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study, Eur Heart J Cardiovasc Imaging, vol.17, pp.326-359, 2016.

S. M. Lang, S. Shugh, W. Mazur, J. J. Sticka, M. S. Rattan et al., Myocardial fibrosis and left ventricular dysfunction in Duchenne muscular dystrophy carriers using cardiac magnetic resonance imaging, Pediatr Cardiol, vol.36, pp.1495-501, 2015.

J. J. Parent, R. A. Moore, M. D. Taylor, J. A. Towbin, and J. L. Jefferies, Left ventricular noncompaction cardiomyopathy in Duchenne muscular dystrophy carriers, J Cardiol Cases, vol.11, pp.7-9, 2015.

J. Schelhorn, A. Schoenecker, U. Neudorf, H. Schemuth, F. Nensa et al., Cardiac pathologies in female carriers of Duchenne muscular dystrophy assessed by cardiovascular magnetic resonance imaging, Eur Radiol, vol.25, pp.3066-72, 2015.

V. E. Cheng and D. L. Prior, Peripartum cardiomyopathy in a previously asymptomatic carrier of Duchenne muscular dystrophy, Heart Lung Circ, vol.22, pp.677-81, 2013.

H. R. Martinez, R. Pignatelli, J. W. Belmont, W. J. Craigen, and J. L. Jefferies, Childhood onset of left ventricular dysfunction in a female manifesting carrier of muscular dystrophy, Am J Med Genet A, vol.155, pp.3025-3034, 2011.

A. Yilmaz, H. J. Gdynia, A. C. Ludolph, K. Klingel, R. Kandolf et al., Images in cardiovascular medicine. Cardiomyopathy in a Duchenne muscular dystrophy carrier and her diseased son: similar pattern revealed by cardiovascular MRI, Circulation, vol.121, pp.237-246, 2010.

T. Walcher, M. Kunze, P. Steinbach, A. D. Sperfeld, C. Burgstahler et al., Cardiac involvement in a female carrier of Duchenne muscular dystrophy, Int J Cardiol, vol.138, pp.302-307, 2010.

A. Helderman-van-den-enden, J. C. Van-den-bergen, M. H. Breuning, J. Verschuuren, A. Tibben et al., Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?, Clin Genet, vol.79, pp.236-278, 2011.

L. Bogue, H. Peay, A. Martin, A. Lucas, and S. Ramchandren, Knowledge of carrier status and barriers to testing among mothers of sons with Duchenne or Becker muscular dystrophy, Neuromuscul Disord, vol.26, pp.860-864, 2016.

L. Bogue and S. Ramchandren, Outdated risk assessment in a family with Duchenne dystrophy: implications for duty to reassess, Neurol Genet, vol.2, p.103, 2016.

R. Mcgowan, B. R. Challoner, S. Ross, S. Holloway, S. Joss et al., Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades?, Clin Genet, vol.83, pp.187-90, 2013.

. Duchenneconnect and . Duchenneconnect, DecodeDuchenne-frequently asked questions, 2018.

J. A. Ellis, E. Vroom, and F. Muntoni, ENMC International Workshop: newborn screening for Duchenne muscular dystrophy, Neuromuscul Disord, vol.23, pp.682-691, 2012.

S. J. Moat, D. M. Bradley, R. Salmon, A. Clarke, and L. Hartley, Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK), Eur J Hum Genet, vol.21, pp.1049-53, 2013.

J. R. Mendell, C. Shilling, N. D. Leslie, K. M. Flanigan, R. Dahhak et al., Evidence-based path to newborn screening for Duchenne muscular dystrophy, Ann Neurol, vol.71, pp.304-317, 2012.

J. M. Kwon, A. Hz, A. Sa, J. R. Mendell, A. Kennedy et al., Clinical follow-up for Duchenne muscular dystrophy newborn screening: a proposal, Muscle Nerve, vol.54, pp.186-91, 2016.

Q. Ke, Z. Y. Zhao, R. Griggs, V. Wiley, A. Connolly et al., Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment, World J Pediatr, vol.13, pp.197-201, 2017.

M. F. Wood, S. C. Hughes, L. P. Hache, E. W. Naylor, A. Hz et al., Parental attitudes toward newborn screening for Duchenne/Becker muscular dystrophy and spinal muscular atrophy, Muscle Nerve, vol.49, pp.822-830, 2014.

S. E. Lillie, B. A. Tarini, N. K. Janz, and B. J. Zikmund-fisher, Framing optional genetic testing in the context of mandatory newborn screening tests, BMC Med Inform Decis Mak, vol.15, p.50, 2015.

H. Wang, Y. Xu, X. Liu, L. Wang, W. Jiang et al., Prenatal diagnosis of Duchenne muscular dystrophy in 131 Chinese families with dystrophinopathy, Prenat Diagn, vol.37, pp.356-64, 2017.

A. T. Helderman-van-den-enden, K. Madan, M. H. Breuning, A. H. Van-der-hout, E. Bakker et al., An urgent need for a change in policy revealed by a study on prenatal testing for Duchenne muscular dystrophy, Eur J Hum Genet, vol.21, pp.21-27, 2013.

. Eshg, Genetic testing in asymptomatic minors: recommendations of the European Society of Human Genetics, Eur J Hum Genet, vol.17, pp.720-721, 2008.

L. Merlini, A. Cicognani, E. Malaspina, M. Gennari, S. Gnudi et al., Early prednisone treatment in Duchenne muscular dystrophy, Muscle Nerve, vol.27, pp.222-229, 2003.

L. Merlini, M. Gennari, E. Malaspina, I. Cecconi, A. Armaroli et al., Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up, Muscle Nerve, vol.45, pp.796-802, 2012.